Discovery may help provide clues for fighting and treating HPV
Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells. Their findings, published online today in the journal Cell, may eventually help to broaden the scope of defenses against HPV and provide valuable clues for delivering drugs into cells. HPV is a family of killers. Although there are effective vaccines against these viruses, they still cause about 5% of cancer deaths worldwide, including more than 250,000 women who die of cervical cancer each year.
New Simple Proteins Play Active Role in Cellular Function
Yale scientists have developed simple new proteins almost devoid of chemical diversity that still play a surprisingly active and specific role in cellular function, causing cells to act like cancer cells, they report Aug. 10 in the Proceedings of the National Academy of Sciences.
New technology could be game changer for people living with Type 1 diabetes
There's a new high-tech tool that could be a game-changer for people with Type 1 diabetes. Yale Principal Investigator and Associate Professor in Pediatrics (Endocrinology), Jennifer Sherr, discusses the Omnipod 5, which monitors insulin levels through a sensor on the skin, then sends the insulin directly through the patch as needed.Source: WNYT.com
Yale VAMOS Program Provides Holistic Vascular Care
The Vascular Medicine OutcomeS (VAMOS) program at Yale University, an integral program supported by the Yale New Haven Health’s Heart and Vascular Center and Center for Musculoskeletal Care, includes a global team of interventional cardiologists, vascular surgeons, podiatrists, radiologists, allied health professionals, and outcomes researchers committed to transforming how PAD is diagnosed and treated, and how patients access care.
Four Yale Researchers Honored at the 2022 Association for Clinical and Translational Science Awards
The collaboration that advanced the discovery of ketamine as a treatment for depression was among four Yale award winners at the Association for Clinical and Translational Science (ACTS) annual meeting held in Chicago from April 20 through 22.
Yale Pathologists Participating in Annual USCAP Meeting to Share Research, Advancements
Pathologists and research scientists from Department of Pathology at Yale School of Medicine will be involved in more than 40 presentations and sessions at the United States and Canadian Academy of Pathology (USCAP) 2022 Annual Meeting in Los Angeles March 19-24.
Linda Coleman accepts appointment to the Board of Directors, Association for the Accreditation of Human Research Protection Programs
Linda Coleman, JD, the Director of the Yale Human Research Protection Program (HRPP), which assists Yale University in meeting its ethical and regulatory obligations for the protection of human research participants, has accepted an appointment to the Board of Directors of the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sex Differences in Brain Cell Development Offer Clues Into Disease Risk
A new Yale study reveals that astrocytes, a type of glial cell found in the central nervous system, develop at different rates in male and female mice, differences that could affect how neural networks are constructed and may have implications for disease risk. The findings were published Feb. 1 in Cell Reports.
For child care programs, masking helped minimize closures, study shows
A new Yale study that followed more than 6,600 child care professionals across the 50 states found that programs practicing child masking early in the pandemic saw lower rates of program interruption compared with those that did not.
YCCI’s Tesheia Johnson Appointed to CTSA Steering Committee
The National Center for Advancing Translational Sciences (NCATS) has announced the new members of its Clinical and Translational Science Awards (CTSA) Program steering committee, including Yale School of Medicine Director of Clinical Research and Yale Center for Clinical Investigation (YCCI) Chief Operating Officer Tesheia Johnson, MBA, MHS. The steering committee provides direction to NCATS and the more than 60 CTSA-funded institutions around the country, including Yale.
Real-world outcomes study targets patients undergoing intravascular lithotripsy treatment at Yale
An observational study at the Heart and Vascular Center (HVC) at Yale New Haven Hospital (YNHH) Heart and Vascular Center could have major implications for patients with peripheral artery disease or PAD.